{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T16:21:04Z","timestamp":1784996464844,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.bonr.2022.101639","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T02:28:49Z","timestamp":1668997729000},"page":"101639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Romosozumab improves low bone mineral density in a postmenopausal woman undergoing chronic hemodialysis and treated with a calcium-sensing receptor agonist"],"prefix":"10.1016","volume":"17","author":[{"given":"Masatomo","family":"Ogata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Ushimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Fujishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Sumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Shiizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bonr.2022.101639_bb0005","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/jbmr.3165","article-title":"Intermittent parathyroid hormone after prolonged alendronate treatment induces substantial new bone formation and increases bone tissue heterogeneity in ovariectomized rats","volume":"32","author":"Altman-Singles","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2022.101639_bb0010","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1210\/en.2005-0239","article-title":"Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis","volume":"146","author":"Bellido","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bonr.2022.101639_bb0015","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bonr.2022.101639_bb0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1152\/physrev.2001.81.1.239","article-title":"Extracellular calcium sensing and extracellular calcium signaling","volume":"81","author":"Brown","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bonr.2022.101639_bb0025","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/jbmr.3735","article-title":"Bone-forming and antiresorptive effects of romosozumab in postmenopausal women with osteoporosis: bone histomorphometry and microcomputed tomography analysis after 2 and 12 months of treatment","volume":"34","author":"Chavassieux","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2022.101639_bb0030","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1210\/jc.2010-0720","article-title":"Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women","volume":"95","author":"Drake","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl. 4","key":"10.1016\/j.bonr.2022.101639_bb0035","first-page":"9","article-title":"Strontium ranelate improves bone microarchitecture in osteoporosis","volume":"iv","author":"Hamdy","year":"2009","journal-title":"Rheumatol. (Oxford)"},{"key":"10.1016\/j.bonr.2022.101639_bb0040","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.bbrc.2014.03.079","article-title":"New insights into the location and form of sclerostin","volume":"446","author":"Hernandez","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.bonr.2022.101639_bb0045","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/jcph.2050","article-title":"Influence of renal function on pharmacokinetics, pharmacodynamics, and safety of a single dose of romosozumab","volume":"62","author":"Hsu","year":"2022","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bonr.2022.101639_bb0050","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/bbrc.1999.0932","article-title":"High extracellular calcium inhibits osteoclast-like cell formation by directly acting on the calcium-sensing receptor existing in osteoclast precursor cells","volume":"261","author":"Kanatani","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bonr.2022.101639_bb0055","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2005.03.018","article-title":"SOST is a target gene for PTH in bone","volume":"37","author":"Keller","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2022.101639_bb0060","first-page":"317","article-title":"Sclerostin as a potential novel biomarker for aortic valve calcification: an in-vivo and ex-vivo study","volume":"22","author":"Koos","year":"2013","journal-title":"J. Heart Valve Dis."},{"key":"10.1016\/j.bonr.2022.101639_bb0065","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0140-6736(17)31613-6","article-title":"Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial","volume":"390","author":"Langdahl","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bonr.2022.101639_bb0070","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s40620-017-0397-7","article-title":"Adynamic bone disease is a predominant bone pattern in early stages of chronic kidney disease","volume":"30","author":"Massy","year":"2017","journal-title":"J. Nephrol."},{"key":"10.1016\/j.bonr.2022.101639_bb0075","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bonr.2022.101639_bb0080","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/jbmr.4563","article-title":"Efficacy and safety of romosozumab among postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease","volume":"37","author":"Miller","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2022.101639_bb0085","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1210\/jc.2009-2283","article-title":"Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women","volume":"95","author":"Mirza","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bonr.2022.101639_bb0090","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00774-022-01332-8","article-title":"Efficacy and safety of romosozumab among japanese postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease","volume":"40","author":"Miyauchi","year":"2022","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bonr.2022.101639_bb0095","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jbmr.2372","article-title":"Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy","volume":"30","author":"Moe","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2022.101639_bb0100","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s00774-021-01253-y","article-title":"Efficacy of romosozumab in patients with osteoporosis on maintenance hemodialysis in Japan; an observational study","volume":"39","author":"Sato","year":"2021","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bonr.2022.101639_bb0105","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bone.2004.05.023","article-title":"Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation","volume":"35","author":"Sutherland","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2022.101639_bb0110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00223-012-9595-4","article-title":"Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness","volume":"90","author":"Thambiah","year":"2012","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bonr.2022.101639_bb0115","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.ajkd.2020.02.450","article-title":"Risks of hip and nonvertebral fractures in patients with ckd g3a\u2013g5d: a systematic review and meta-analysis","volume":"76","author":"Vilaca","year":"2020","journal-title":"Am. J. Kidney Dis."}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187222004739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187222004739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T16:28:17Z","timestamp":1762446497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187222004739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":23,"alternative-id":["S2352187222004739"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2022.101639","relation":{},"ISSN":["2352-1872"],"issn-type":[{"value":"2352-1872","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Romosozumab improves low bone mineral density in a postmenopausal woman undergoing chronic hemodialysis and treated with a calcium-sensing receptor agonist","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2022.101639","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101639"}}